Increased brain retention of Tc-99m HMPAO following acetazolamide administration

Clin Nucl Med. 1991 Aug;16(8):568-71. doi: 10.1097/00003072-199108000-00007.

Abstract

Sixty-five patients referred for Tc-99m HMPAO SPECT brain perfusion studies had measurements of global Tc-99m HMPAO retention after injection at rest and after acetazolamide pretreatment. Acetazolamide produced relative changes in Tc-99m HMPAO retention similar to those previously reported with Xe-133 regional cerebral blood flow (rCBF) measurements. This addition to imaging protocols allows another objective evaluation of the cerebral vascular reserve.

MeSH terms

  • Acetazolamide*
  • Brain / diagnostic imaging*
  • Cerebrovascular Circulation / drug effects*
  • Cerebrovascular Disorders / diagnostic imaging*
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds
  • Oximes
  • Stimulation, Chemical
  • Technetium Tc 99m Exametazime
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Organotechnetium Compounds
  • Oximes
  • Technetium Tc 99m Exametazime
  • Acetazolamide